Biography and Research Information
OverviewAI-generated summary
Sunil Sharma's research interests encompass drug delivery systems, supramolecular chemistry, and the synthesis of novel chemical compounds for therapeutic applications. His work has explored the use of guar gum in drug delivery and reviewed the self-assembly of carbohydrate-based amphiphiles for pathogen inhibition and drug delivery.
Sharma has also investigated the design and synthesis of anti-inflammatory compounds, focusing on their molecular structure and selectivity for targets such as COX-2. His publication record includes work on conjugated polymers for electroluminescence in quantum dot layers, as well as research into the long-term effects of hepatitis B virus infection and the therapeutic efficacy of specific drug combinations for lymphoma.
With a career marked by significant scholarly output, Sharma holds an h-index of 37 and has authored 385 publications, accumulating nearly 5,000 citations. He is recognized as a highly cited researcher, indicating substantial impact within his fields. His recent activity suggests ongoing engagement in research, with publications extending to 2024 and a designation of being recently active.
Metrics
- h-index: 37
- Publications: 385
- Citations: 4,990
Selected Publications
-
Unraveling the chemistry, pharmacological activities, and medicinal utilization of phloroglucinol: A comprehensive review (2025)
-
2688MO A phase I/II trial of FOG-001, a first-in-class direct β-catenin:TCF4 inhibitor - Safety and preliminary antitumor activity in patients with desmoid tumors (2025)
-
Abstract B031: A phase 1/2 trial of FOG-001, a first-in-class direct β-catenin:TCF4 inhibitor, preliminary safety and efficacy in patients with solid tumors bearing Wnt pathway-activating mutations (WPAM+) (2025)
-
Tuning magneto-dielectric properties of Bi-doped U-type hexaferrites via Maxwell-Wagner polarization engineering (2025)
-
Modulation of Nrf-2/HO-1/HIF-1α/TFAM pathways by Arbutin in rat model of cerebral ischemic stroke (2025)
-
NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer (2025)
-
A Randomized Phase II Trial of Gemcitabine, Nab-Paclitaxel, Cisplatin with or without a Medically Supervised Ketogenic Diet for Patients with Metastatic Pancreatic Cancer (2025)
-
Study on the Self-Assembly and Dual-Stimuli-Responsive Behavior of Multi-amphiphilic Polymeric Architectures (2025)
-
Phase 1/2 study of FOG-001, a first-in-class direct β-catenin:TCF inhibitor, in patients with colorectal cancer, hepatocellular carcinoma, and other locally advanced or metastatic solid tumors. (2025)
-
Efficient synthesis of coumarin based triazole linked O-glycoconjugates as new bio-active glycohybrids (2025)
-
Retracted: Improved Detection Rate of Breast Cancer Using 3D Magnetic Resonance Imaging (2024)
-
Phase 1/2 trial of the HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab: Clinical update. (2024)
-
A first-in-human, phase 1/2 trial of FOG-001, a β-catenin:TCF antagonist, in patients with locally advanced or metastatic solid tumors. (2024)
-
Efficient synthesis and in-silico studies of pyrano[3,2-c]pyrones based glycohybrids (2024)
-
Stimuli-responsive azo-functionalized non-ionic amphiphiles for controlled drug delivery applications (2024)
Collaboration Network
Top Collaborators
Krishna
Rensselaer Polytechnic Institute (US)
6 shared publications
- Self-assembly of carbohydrate-based small amphiphiles and their applications in pathogen inhibition and drug delivery: a review
- Newer Non‐ionic A<sub>2</sub>B<sub>2</sub>‐Type Enzyme‐Responsive Amphiphiles for Drug Delivery
- Synthesis and transport potential study of <scp>A<sub>2</sub>B</scp> type double chain amphiphilic architectures
- Stimuli-responsive azo-functionalized non-ionic amphiphiles for controlled drug delivery applications
- Fabrication of hydrolase responsive diglycerol based Gemini amphiphiles for dermal drug delivery applications
Showing 5 of 6 shared publications
Rainer Haag
Freie Universität Berlin (DE)
6 shared publications
- Supramolecular Engineering of Alkylated, Fluorinated, and Mixed Amphiphiles
- Newer Non‐ionic A<sub>2</sub>B<sub>2</sub>‐Type Enzyme‐Responsive Amphiphiles for Drug Delivery
- Fabrication of hydrolase responsive diglycerol based Gemini amphiphiles for dermal drug delivery applications
- Study on the Self-Assembly and Dual-Stimuli-Responsive Behavior of Multi-amphiphilic Polymeric Architectures
- Evaluation of Transport Potential of Alkylated and Fluoroalkylated Amphiphilic Hybrid Nanoarchitectures
Showing 5 of 6 shared publications
Katharina Achazi
Freie Universität Berlin (DE)
5 shared publications
- Newer Non‐ionic A<sub>2</sub>B<sub>2</sub>‐Type Enzyme‐Responsive Amphiphiles for Drug Delivery
- Fabrication of hydrolase responsive diglycerol based Gemini amphiphiles for dermal drug delivery applications
- Study on the Self-Assembly and Dual-Stimuli-Responsive Behavior of Multi-amphiphilic Polymeric Architectures
- Evaluation of Transport Potential of Alkylated and Fluoroalkylated Amphiphilic Hybrid Nanoarchitectures
- Synthesis of <i>C</i><sub>3</sub>-symmetric star shaped amphiphiles for drug delivery applications
Badri Parshad
Massachusetts General Hospital (US)
4 shared publications
- Self-assembly of carbohydrate-based small amphiphiles and their applications in pathogen inhibition and drug delivery: a review
- Newer Non‐ionic A<sub>2</sub>B<sub>2</sub>‐Type Enzyme‐Responsive Amphiphiles for Drug Delivery
- Stimuli-responsive azo-functionalized non-ionic amphiphiles for controlled drug delivery applications
- Study on the Self-Assembly and Dual-Stimuli-Responsive Behavior of Multi-amphiphilic Polymeric Architectures
Aarti Aarti
University of Delhi (IN)
4 shared publications
- Self-assembly of carbohydrate-based small amphiphiles and their applications in pathogen inhibition and drug delivery: a review
- Leveraging immunoliposomes as nanocarriers against SARS-CoV-2 and its emerging variants
- Synthesis and transport potential study of <scp>A<sub>2</sub>B</scp> type double chain amphiphilic architectures
- Synthesis of <i>C</i><sub>3</sub>-symmetric star shaped amphiphiles for drug delivery applications
Meredith S. Pelster
Sarah Cannon (US)
4 shared publications
- A first-in-human, phase 1/2 trial of FOG-001, a β-catenin:TCF antagonist, in patients with locally advanced or metastatic solid tumors.
- A Randomized Phase II Trial of Gemcitabine, Nab-Paclitaxel, Cisplatin with or without a Medically Supervised Ketogenic Diet for Patients with Metastatic Pancreatic Cancer
- Phase 1/2 study of FOG-001, a first-in-class direct β-catenin:TCF inhibitor, in patients with colorectal cancer, hepatocellular carcinoma, and other locally advanced or metastatic solid tumors.
- Abstract B031: A phase 1/2 trial of FOG-001, a first-in-class direct β-catenin:TCF4 inhibitor, preliminary safety and efficacy in patients with solid tumors bearing Wnt pathway-activating mutations (WPAM+)
Christoph Böttcher
Freie Universität Berlin (DE)
3 shared publications
- Supramolecular Engineering of Alkylated, Fluorinated, and Mixed Amphiphiles
- Newer Non‐ionic A<sub>2</sub>B<sub>2</sub>‐Type Enzyme‐Responsive Amphiphiles for Drug Delivery
- Study on the Self-Assembly and Dual-Stimuli-Responsive Behavior of Multi-amphiphilic Polymeric Architectures
Ayushi Mittal
University of Delhi (IN)
3 shared publications
- Self-assembly of carbohydrate-based small amphiphiles and their applications in pathogen inhibition and drug delivery: a review
- Fabrication of hydrolase responsive diglycerol based Gemini amphiphiles for dermal drug delivery applications
- Synthesis of <i>C</i><sub>3</sub>-symmetric star shaped amphiphiles for drug delivery applications
Antara Sharma
University of Delhi (IN)
3 shared publications
- Synthesis and transport potential study of <scp>A<sub>2</sub>B</scp> type double chain amphiphilic architectures
- Stimuli-responsive azo-functionalized non-ionic amphiphiles for controlled drug delivery applications
- Self‐Assembly and Transport Behaviour of Non‐ionic Fluorinated and Alkylated Amphiphiles for Drug Delivery
Saima Syeda
University of Delhi (IN)
3 shared publications
- Synthesis and transport potential study of <scp>A<sub>2</sub>B</scp> type double chain amphiphilic architectures
- Stimuli-responsive azo-functionalized non-ionic amphiphiles for controlled drug delivery applications
- Self‐Assembly and Transport Behaviour of Non‐ionic Fluorinated and Alkylated Amphiphiles for Drug Delivery
Anju Shrivastava
University of Delhi (IN)
3 shared publications
- Synthesis and transport potential study of <scp>A<sub>2</sub>B</scp> type double chain amphiphilic architectures
- Stimuli-responsive azo-functionalized non-ionic amphiphiles for controlled drug delivery applications
- Self‐Assembly and Transport Behaviour of Non‐ionic Fluorinated and Alkylated Amphiphiles for Drug Delivery
Jamie Hirata
3 shared publications
- Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
- Polatuzumab vedotin, venetoclax, and an <scp>anti‐CD20</scp> monoclonal antibody in relapsed/refractory B‐cell <scp>non‐Hodgkin</scp> lymphoma
- A Phase Ib/II Study of Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in Patients with Relapsed/Refractory Follicular Lymphoma: Final Analysis and Progression-Free Survival Update
Lisa Musick
3 shared publications
- Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
- Polatuzumab vedotin, venetoclax, and an <scp>anti‐CD20</scp> monoclonal antibody in relapsed/refractory B‐cell <scp>non‐Hodgkin</scp> lymphoma
- A Phase Ib/II Study of Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in Patients with Relapsed/Refractory Follicular Lymphoma: Final Analysis and Progression-Free Survival Update
Indu Sharma
Career Point University (IN)
3 shared publications
- Improved magneto-dielectric response and dielectric characteristics of rare earth doped Ba and Co based U-type hexaferrite
- Tuning magneto-dielectric properties of Bi-doped U-type hexaferrites via Maxwell-Wagner polarization engineering
- Existence of Magneto-Resistance and Magneto-Dielectric Effect in Composite of Perovskite Pb<sub>0.79</sub>Nd<sub>0.21</sub>TiO<sub>3</sub> and Sr -Based U-Type Hexaferrite (Sr<sub>1–3x</sub>Nd<sub>2x</sub>)<sub>4</sub>Co<sub>2</sub>Fe<sub>36</sub>O<sub>60</sub>
Kyriakos P. Papadopoulos
3 shared publications
- A first-in-human, phase 1/2 trial of FOG-001, a β-catenin:TCF antagonist, in patients with locally advanced or metastatic solid tumors.
- Phase 1/2 study of FOG-001, a first-in-class direct β-catenin:TCF inhibitor, in patients with colorectal cancer, hepatocellular carcinoma, and other locally advanced or metastatic solid tumors.
- Abstract B031: A phase 1/2 trial of FOG-001, a first-in-class direct β-catenin:TCF4 inhibitor, preliminary safety and efficacy in patients with solid tumors bearing Wnt pathway-activating mutations (WPAM+)
Similar Researchers
Based on overlapping research topics
Cynthia Wyman Bookwalter
University of Arkansas at Little Rock
Nanoparticles: synthesis and applications
Immune Response and Inflammation
Cancer Treatment and Pharmacology
Odo Lovelyn Onyinyechi
University of Arkansas at Fayetteville
Drug Delivery Systems
Nanoparticles: synthesis and applications
Cancer Treatment and Pharmacology
Zachary Heidrick
University of Arkansas at Fayetteville
Drug Delivery Systems
Nanoparticles: synthesis and applications
Cancer Treatment and Pharmacology
Carlie M. Clem
University of Arkansas at Fayetteville
Drug Delivery Systems
Nanoparticles: synthesis and applications
Microbial infections and disease research
Charlette M. Parnell
University of Arkansas at Little Rock
Drug Delivery Systems
Nanoparticles: synthesis and applications
Cancer Treatment and Pharmacology
Ruud P.M. Dings
University of Arkansas at Fayetteville
Nanoparticles: synthesis and applications
Immune Response and Inflammation
Cancer Treatment and Pharmacology